Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 353

    1.

    Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa-Dependent Manner.

    Ahlenstiel G, Titerence RH, Koh C, Edlich B, Feld JJ, Rotman Y, Ghany MG, Hoofnagle JH, Liang TJ, Heller T, Rehermann B.

    Gastroenterology. 2009 Sep 10. [Epub ahead of print]PMID: 19747917 [PubMed - as supplied by publisher]Related articles

    2.

    Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.

    Palmore TN, Shah NL, Loomba R, Borg BB, Lopatin U, Feld JJ, Khokhar F, Lutchman G, Kleiner DE, Young NS, Childs R, Barrett AJ, Liang TJ, Hoofnagle JH, Heller T.

    Clin Gastroenterol Hepatol. 2009 Oct;7(10):1130-7. Epub 2009 Jul 1.PMID: 19577007 [PubMed - in process]Related articles

    3.

    Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C.

    Dove LM, Rosen RC, Ramcharran D, Wahed AS, Belle SH, Brown RS, Hoofnagle JH; Virahep-C Study Group.

    Gastroenterology. 2009 Sep;137(3):873-84, 884.e1. Epub 2009 Jun 13.PMID: 19527724 [PubMed - indexed for MEDLINE]Related articles

    4.

    A step forward in therapy for hepatitis C.

    Hoofnagle JH.

    N Engl J Med. 2009 Apr 30;360(18):1899-901. No abstract available. PMID: 19403908 [PubMed - indexed for MEDLINE]Related articles

    5.

    Evaluation of the patient with hepatitis B.

    Rotman Y, Brown TA, Hoofnagle JH.

    Hepatology. 2009 May;49(5 Suppl):S22-7.PMID: 19399815 [PubMed - indexed for MEDLINE]Related articles

    6.

    NIH consensus development conference: management of Hepatitis B. Introduction.

    Doo EC, Hoofnagle JH, Rodgers GP.

    Hepatology. 2009 May;49(5 Suppl):S1-3. No abstract available. PMID: 19399814 [PubMed - indexed for MEDLINE]Related articles

    7.

    The hepatitis B research network.

    Doo EC, Hoofnagle JH.

    Hepatology. 2009 May;49(5 Suppl):S196-7. No abstract available. PMID: 19399805 [PubMed - indexed for MEDLINE]Related articles

    8.

    Reactivation of hepatitis B.

    Hoofnagle JH.

    Hepatology. 2009 May;49(5 Suppl):S156-65.PMID: 19399803 [PubMed - indexed for MEDLINE]Related articles

    9.

    Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection.

    Hoofnagle JH, Wahed AS, Brown RS Jr, Howell CD, Belle SH; Virahep-C Study Group.

    J Infect Dis. 2009 Apr 15;199(8):1112-20.PMID: 19284286 [PubMed - indexed for MEDLINE]Related articles

    10.

    Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C.

    Terrault NA, Im K, Boylan R, Bacchetti P, Kleiner DE, Fontana RJ, Hoofnagle JH, Belle SH; VIRAHEP-C Study Group.

    Clin Gastroenterol Hepatol. 2008 Dec;6(12):1403-11. Epub 2008 Aug 19.PMID: 19081528 [PubMed - indexed for MEDLINE]Related articles

    11.

    Clinical trial: Pilot study of metformin for the treatment of nonalcoholic steatohepatitis.

    Loomba R, Lutchman G, Kleiner DE, Ricks M, Feld JJ, Borg BB, Modi A, Nagabhyru P, Sumner AE, Liang TJ, Hoofnagle JH.

    Aliment Pharmacol Ther. 2008 Oct 9. [Epub ahead of print]PMID: 18945255 [PubMed - as supplied by publisher]Related articles

    12.

    Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.

    Feld JJ, Hussain N, Wright EC, Kleiner DE, Hoofnagle JH, Ahlawat S, Anderson V, Hilligoss D, Gallin JI, Liang TJ, Malech HL, Holland SM, Heller T.

    Gastroenterology. 2008 Jun;134(7):1917-26. Epub 2008 Mar 4.PMID: 18439425 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection.

    Howell CD, Dowling TC, Paul M, Wahed AS, Terrault NA, Taylor M, Jeffers L, Hoofnagle JH; Virahep-C Study Group.

    Clin Gastroenterol Hepatol. 2008 May;6(5):575-83. Epub 2008 Apr 14.PMID: 18407798 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy.

    Loomba R, Rowley A, Wesley R, Liang TJ, Hoofnagle JH, Pucino F, Csako G.

    Ann Intern Med. 2008 Apr 1;148(7):519-28. Review. Erratum in: Ann Intern Med. 2009 May 5;150(9):657-8. PMID: 18378948 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Acute liver failure: Summary of a workshop.

    Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH.

    Hepatology. 2008 Apr;47(4):1401-15.PMID: 18318440 [PubMed - indexed for MEDLINE]Related articles

    16.

    Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.

    Chung RT, Gale M Jr, Polyak SJ, Lemon SM, Liang TJ, Hoofnagle JH.

    Hepatology. 2008 Jan;47(1):306-20. No abstract available. PMID: 18161743 [PubMed - indexed for MEDLINE]Related articles

    17.

    New therapies for hepatitis C.

    Modi AA, Hoofnagle JH.

    Hepatology. 2007 Sep;46(3):615-7. No abstract available. PMID: 17879364 [PubMed - indexed for MEDLINE]Related articles

    18.

    Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop.

    Sokol RJ, Shepherd RW, Superina R, Bezerra JA, Robuck P, Hoofnagle JH.

    Hepatology. 2007 Aug;46(2):566-81. Review.PMID: 17661405 [PubMed - indexed for MEDLINE]Related articles

    19.

    The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis.

    Lutchman G, Modi A, Kleiner DE, Promrat K, Heller T, Ghany M, Borg B, Loomba R, Liang TJ, Premkumar A, Hoofnagle JH.

    Hepatology. 2007 Aug;46(2):424-9.PMID: 17559148 [PubMed - indexed for MEDLINE]Related articles

    20.

    Mutation rate of the hepatitis C virus NS5B in patients undergoing treatment with ribavirin monotherapy.

    Lutchman G, Danehower S, Song BC, Liang TJ, Hoofnagle JH, Thomson M, Ghany MG.

    Gastroenterology. 2007 May;132(5):1757-66. Epub 2007 Mar 24.PMID: 17484873 [PubMed - indexed for MEDLINE]Related articles

    21.

    Management of hepatitis B: summary of a clinical research workshop.

    Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS.

    Hepatology. 2007 Apr;45(4):1056-75. Review.PMID: 17393513 [PubMed - indexed for MEDLINE]Related articles

    22.

    Hepatic abnormalities in patients with chronic granulomatous disease.

    Hussain N, Feld JJ, Kleiner DE, Hoofnagle JH, Garcia-Eulate R, Ahlawat S, Koziel DE, Anderson V, Hilligoss D, Choyke P, Gallin JI, Liang TJ, Malech HL, Holland SM, Heller T.

    Hepatology. 2007 Mar;45(3):675-83.PMID: 17326162 [PubMed - indexed for MEDLINE]Related articles

    23.

    Race, insulin resistance and hepatic steatosis in chronic hepatitis C.

    Conjeevaram HS, Kleiner DE, Everhart JE, Hoofnagle JH, Zacks S, Afdhal NH, Wahed AS; Virahep-C Study Group.

    Hepatology. 2007 Jan;45(1):80-7.PMID: 17187406 [PubMed - indexed for MEDLINE]Related articles

    24.

    Overweight, obesity, and mortality.

    Hoofnagle JH.

    N Engl J Med. 2006 Dec 21;355(25):2699; author reply 2700-1. No abstract available. PMID: 17186585 [PubMed - indexed for MEDLINE]Related articles

    25.

    Peginterferon and ribavirin for chronic hepatitis C.

    Hoofnagle JH, Seeff LB.

    N Engl J Med. 2006 Dec 7;355(23):2444-51. Review. No abstract available. PMID: 17151366 [PubMed - indexed for MEDLINE]Related articles

    26.

    Epidemiologic research and the action plan for liver disease research.

    Miller ME, Everhart JE, Hoofnagle JH.

    Ann Epidemiol. 2006 Nov;16(11):861-5. Epub 2006 Oct 24. No abstract available. PMID: 17067816 [PubMed - indexed for MEDLINE]Related articles

    27.

    Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection.

    Fontana RJ, Kleiner DE, Bilonick R, Terrault N, Afdhal N, Belle SH, Jeffers LJ, Ramcharran D, Ghany MG, Hoofnagle JH; Virahep-C Study Group.

    Hepatology. 2006 Oct;44(4):925-35.PMID: 17006909 [PubMed - indexed for MEDLINE]Related articles

    28.

    Primary sclerosing cholangitis: summary of a workshop.

    LaRusso NF, Shneider BL, Black D, Gores GJ, James SP, Doo E, Hoofnagle JH.

    Hepatology. 2006 Sep;44(3):746-64. Review.PMID: 16941705 [PubMed - indexed for MEDLINE]Related articles

    29.

    Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

    Conjeevaram HS, Fried MW, Jeffers LJ, Terrault NA, Wiley-Lucas TE, Afdhal N, Brown RS, Belle SH, Hoofnagle JH, Kleiner DE, Howell CD; Virahep-C Study Group.

    Gastroenterology. 2006 Aug;131(2):470-7.PMID: 16890601 [PubMed - indexed for MEDLINE]Related articles

    30.

    Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement.

    Lutchman G, Promrat K, Kleiner DE, Heller T, Ghany MG, Yanovski JA, Liang TJ, Hoofnagle JH.

    Clin Gastroenterol Hepatol. 2006 Aug;4(8):1048-52. Epub 2006 Jun 30.PMID: 16814613 [PubMed - indexed for MEDLINE]Related articles

    31.

    The National Commission on Digestive Diseases.

    Hoofnagle JH.

    Hepatology. 2006 Jul;44(1):6. No abstract available. PMID: 16799964 [PubMed - indexed for MEDLINE]Related articles

    32.

    Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity.

    Seeff LB, Hoofnagle JH.

    Oncogene. 2006 Jun 26;25(27):3771-7. Review.PMID: 16799618 [PubMed - indexed for MEDLINE]Related articles

    33.

    A framework for management of hepatitis C in prisons.

    Spaulding AC, Weinbaum CM, Lau DT, Sterling R, Seeff LB, Margolis HS, Hoofnagle JH.

    Ann Intern Med. 2006 May 16;144(10):762-9. Review.PMID: 16702592 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000.

    Shneider BL, Brown MB, Haber B, Whitington PF, Schwarz K, Squires R, Bezerra J, Shepherd R, Rosenthal P, Hoofnagle JH, Sokol RJ; Biliary Atresia Research Consortium.

    J Pediatr. 2006 Apr;148(4):467-474.PMID: 16647406 [PubMed - indexed for MEDLINE]Related articles

    35.

    Progress on the action plan for liver disease research.

    Hoofnagle JH, Miller ME.

    Hepatology. 2006 May;43(5):890. No abstract available. PMID: 16628663 [PubMed - indexed for MEDLINE]Related articles

    36.

    Neonatal screening for biliary atresia.

    Hoofnagle JH, Sokol RJ.

    Hepatology. 2006 Apr;43(4):646. No abstract available. PMID: 16557564 [PubMed - indexed for MEDLINE]Related articles

    37.

    Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection.

    Perumalswami P, Kleiner DE, Lutchman G, Heller T, Borg B, Park Y, Liang TJ, Hoofnagle JH, Ghany MG.

    Hepatology. 2006 Apr;43(4):780-7.PMID: 16557550 [PubMed - indexed for MEDLINE]Related articles

    38.

    Hepatitis B--preventable and now treatable.

    Hoofnagle JH.

    N Engl J Med. 2006 Mar 9;354(10):1074-6. No abstract available. PMID: 16525145 [PubMed - indexed for MEDLINE]Related articles

    39.

    AASLD 2005 Distinguished Service Award to Dr. Leonard B. Seeff.

    Hoofnagle JH.

    Hepatology. 2005 Dec;42(6):1246-7. No abstract available. PMID: 16317697 [PubMed - indexed for MEDLINE]Related articles

    40.

    Research opportunities on alcohol and liver damage.

    Zakhari S, Hoofnagle JH.

    Hepatology. 2005 Dec;42(6):1243. No abstract available. PMID: 16317668 [PubMed - indexed for MEDLINE]Related articles

    41.

    Hepatitis B.

    Hoofnagle JH.

    Hepatology. 2005 Oct;42(4):748. No abstract available. PMID: 16175614 [PubMed - indexed for MEDLINE]Related articles

    42.

    Peginterferon Alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection.

    Borg BB, Hoofnagle JH.

    N Engl J Med. 2005 Sep 15;353(11):1182-3; author reply 1182-3. No abstract available. PMID: 16162894 [PubMed - indexed for MEDLINE]Related articles

    43.

    Mechanism of action of interferon and ribavirin in treatment of hepatitis C.

    Feld JJ, Hoofnagle JH.

    Nature. 2005 Aug 18;436(7053):967-72. Review.PMID: 16107837 [PubMed - indexed for MEDLINE]Related articles

    44.

    Milk thistle and chronic liver disease.

    Hoofnagle JH.

    Hepatology. 2005 Jul;42(1):4. No abstract available. PMID: 15962321 [PubMed - indexed for MEDLINE]Related articles

    45.

    Pilot study of interferon gamma for chronic hepatitis C.

    Soza A, Heller T, Ghany M, Lutchman G, Jake Liang T, Germain J, Hsu HH, Park Y, Hoofnagle JH.

    J Hepatol. 2005 Jul;43(1):67-71. Epub 2005 Apr 26.PMID: 15913831 [PubMed - indexed for MEDLINE]Related articles

    46.

    Primary sclerosing cholangitis.

    Hoofnagle JH.

    Hepatology. 2005 May;41(5):955. No abstract available. PMID: 15841460 [PubMed - indexed for MEDLINE]Related articles

    47.

    Peds-C.

    Hoofnagle JH.

    Hepatology. 2005 Mar;41(3):421. No abstract available. PMID: 15723319 [PubMed - indexed for MEDLINE]Related articles

    48.

    Hepatocellular carcinoma: summary and recommendations.

    Hoofnagle JH.

    Gastroenterology. 2004 Nov;127(5 Suppl 1):S319-23. Review. No abstract available. PMID: 15508100 [PubMed - indexed for MEDLINE]Related articles

    49.

    Cellular immune responses to the hepatitis B virus polymerase.

    Mizukoshi E, Sidney J, Livingston B, Ghany M, Hoofnagle JH, Sette A, Rehermann B.

    J Immunol. 2004 Nov 1;173(9):5863-71.PMID: 15494540 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Drug-induced liver injury network (DILIN).

    Hoofnagle JH.

    Hepatology. 2004 Oct;40(4):773. No abstract available. PMID: 15382161 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...